Japanese Journal of Clinical Oncology logo Oxford University Press logo

JJCO was established in 1971 as the first journal from Japan to publish clinical research on cancer in English. It was a biannual journal for the first 11 years, and as the number of submissions increased, it became quarterly in 1983 and bimonthly in 1991. Since 1998, the JJCO has been published monthly.

Publisher: Oxford University Press

Related content
Volume 39, Number 5, 31 May 2009

< previous issue | all issues | next issue >

Chemotherapy with Cisplatin and Vincristine for Optic Pathway/Hypothalamic Astrocytoma in Young Children
pp. 277-283(7)
Authors: Sawamura, Yutaka; Kamoshima, Yuuta; Kato, Tsutomu; Tajima, Toshihiro; Tsubaki, Junko

Positron Emission Tomography-Computed Tomography in the Detection of Axillary Lymph Node Metastasis in Patients with Early Stage Breast Cancer
pp. 284-289(6)
Authors: Chae, Byung Joo; Bae, Ja Seong; Kang, Bong Joo; Kim, Sung Hoon; Jung, Sang Seol; Song, Byung Joo

Expression of the Antiapoptosis Gene Survivin Predicts Poor Prognosis of Stage III Gastric Adenocarcinoma
pp. 290-296(7)
Authors: Song, Kyo Young; Jung, Chan Kwon; Park, Won Sang; Park, Cho Hyun

Clinical Value of Whole-body FDG-PET for Recurrent Gastric Cancer: A Multicenter Study
pp. 297-302(6)
Authors: Nakamoto, Yuji; Togashi, Kaori; Kaneta, Tomohiro; Fukuda, Hiroshi; Nakajima, Kotaro; Kitajima, Kazuhiro; Murakami, Koji; Fujii, Hirofumi; Satake, Mitsuo; Tateishi, Ukihide; Kubota, Kazuo; Senda, Michio

Antitumor Efficacy of Recombinant Human Interleukin-2 Combined with Sorafenib Against Mouse Renal Cell Carcinoma
pp. 303-309(7)
Authors: Iguchi, Motofumi; Matsumoto, Mitsunobu; Hojo, Kanji; Wada, Toru; Matsuo, Yoshiyuki; Arimura, Akinori; Abe, Kenji

Efficacy of Adjuvant Interferon-alpha Therapy Following Curative Resection in Renal Cell Carcinoma: Before the Molecular Targeting Therapy Era
pp. 310-314(5)
Authors: Kai, Fumitake; Takayama, Tatsuya; Sugiyama, Takayuki; Furuse, Hiroshi; Mugiya, Soichi; Ozono, Seiichiro

Retrospective Analysis of S-1 Monotherapy in Patients with Metastatic Colorectal Cancer After Failure to Fluoropyrimidine and Irinotecan or to Fluoropyrimidine, Irinotecan and Oxaliplatin
pp. 315-320(6)
Authors: Yasui, Hirofumi; Yoshino, Takayuki; Boku, Narikazu; Onozawa, Yusuke; Hironaka, Shuichi; Fukutomi, Akira; Yamazaki, Kentaro; Taku, Keisei; Kojima, Takashi; Machida, Nozomu

A Phase 2 Clinical Trial of Panitumumab Monotherapy in Japanese Patients with Metastatic Colorectal Cancer
pp. 321-326(6)
Authors: Muro, Kei; Yoshino, Takayuki; Doi, Toshihiko; Shirao, Kuniaki; Takiuchi, Hiroya; Hamamoto, Yasuo; Watanabe, Hiroyuki; Yang, Bing-Bing; Asahi, Daisuke

Sunitinib, a Novel Therapy for Anthracycline- and Cisplatin-refractory Malignant Pheochromocytoma
pp. 327-331(5)
Authors: Park, Kyung-Sun; Lee, Jae-Lyun; Ahn, Hanjong; Koh, Jung-Min; Park, Inkeun; Choi, Jun-Seok; Kim, Yi Rang; Park, Tai Sun; Ahn, Jin-Hee; Lee, Dae Ho; Kim, Tae Won; Lee, Jung Shin

Activity of S-1 in Advanced or Recurrent Gastric Cancer Patients after Failure of Prior Chemotherapy, Including Irinotecan Cisplatin or Fluorouracil (Except S-1)
pp. 332-335(4)
Authors: Ono, Akira; Boku, Narikazu; Onozawa, Yusuke; Hironaka, Shuichi; Fukutomi, Akira; Yasui, Hiroshi; Yamazaki, Kentaro; Yoshino, Takayuki; Taku, Keisei; Kojima, Takashi

Metastatic Melanoma on the Abdominal Wall
pp. 336-336(1)
Authors: Namikawa, Kenjiro; Yamazaki, Naoya

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page